Site Editor

Rebecca Olin, MD, MS


Andrew H. Wei, MBBS, PhD, on Safely Administering a Venetoclax-Containing Regimen to Older Patients With AML

Posted: Tuesday, July 28, 2020

Andrew H. Wei, MBBS, PhD, of The Alfred Hospital, Monash University, discusses findings of the VIALE-C trial for previously untreated older patients with acute myeloid leukemia and offers recommendations for the safe administration of a venetoclax-containing regimen.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.